Trendlines Establishes a Subsidiary in Singapore

Trendlines Chairman and CEO Steve Rhodes introduces The Trendlines Group in Singapore, at the first event of the Trendlines Medical Asia Road Show, which was held in early July.

Trendlines has incorporated a wholly owned subsidiary in Singapore, Trendlines Medical Singapore Pte. Ltd. (Trendlines Medical Singapore), which is intended to be a platform for investment in and incubation of early-stage health care companies. Read the full company announcement.

Editor’s note: News about the announcement appeared in Globes.

Israel’s Trendlines to set up Singapore medtech incubator

By Gali Weinreb, 20 July 2016 (Globes English)

The incubator will be based on ideas originating at universities, and government research institutes in the region.

Israeli investment company Trendlines Ltd. (SI:42T) has announced that it is founding a medical technology incubator in Singapore. Trendlines operates a medical technology incubator in Israel and a fund for investing in mature companies from the incubator, is active in R&D for international corporations, and is a partner in a fund with international company Bayer for agtech investments. Trendlines’ market cap is 96.99 million Singapore dollars ($71.25 million), after holding its IPO in November 2015 [where it raised] 38 million Singapore dollars ($28 million). German company B. Braun Melsungen AG was the leading investor in the IPO with an investment of 7.1 million Singapore dollars ($5 million). Read the full article in Globes.